2LM0
| Solution structure of the AF4-AF9 complex | Descriptor: | AF4/FMR2 family member 1/Protein AF-9 chimera | Authors: | Leach, B.I, Kuntimaddi, A, Schmidt, C.R, Cierpicki, T, Johnson, S.A, Bushweller, J.H. | Deposit date: | 2011-11-18 | Release date: | 2013-01-09 | Last modified: | 2024-05-01 | Method: | SOLUTION NMR | Cite: | Leukemia Fusion Target AF9 Is an Intrinsically Disordered Transcriptional Regulator that Recruits Multiple Partners via Coupled Folding and Binding. Structure, 21, 2013
|
|
8T5X
| Probing the dissociation pathway of a kinetically labile transthyretin mutant (A25T) | Descriptor: | Transthyretin | Authors: | Ferguson, J.A, Sun, X, Leach, B.I, Stanfield, R.L, Dyson, H.J, Wright, P.E. | Deposit date: | 2023-06-14 | Release date: | 2023-08-02 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.63 Å) | Cite: | Probing the Dissociation Pathway of a Kinetically Labile Transthyretin Mutant. J.Am.Chem.Soc., 146, 2024
|
|
6B7G
| Solution NMR structure of BCoR in complex with AF9 (BCoR-AF9) | Descriptor: | BCL-6 corepressor, Protein AF-9 | Authors: | Schmidt, C.R, Kuntimaddi, A, Leach, B.I, Bushweller, J.H. | Deposit date: | 2017-10-04 | Release date: | 2018-10-10 | Last modified: | 2024-05-15 | Method: | SOLUTION NMR | Cite: | BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity. Blood Cancer Discov, 1, 2020
|
|
2N4Q
| |